BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7604141)

  • 1. The effect of carbamazepine on the 2-hydroxylation of desipramine.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Psychopharmacology (Berl); 1995 Feb; 117(4):413-6. PubMed ID: 7604141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital induces the 2-hydroxylation of desipramine.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Ther Drug Monit; 1996 Feb; 18(1):60-4. PubMed ID: 8848823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desipramine pharmacokinetics in Chinese and Caucasian volunteers.
    Rudorfer MV; Lane EA; Chang WH; Zhang MD; Potter WZ
    Br J Clin Pharmacol; 1984 Apr; 17(4):433-40. PubMed ID: 6721989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of desipramine 2-hydroxylation by quinidine and quinine.
    Steiner E; Dumont E; Spina E; Dahlqvist R
    Clin Pharmacol Ther; 1988 May; 43(5):577-81. PubMed ID: 3365919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the inhibitory effect of cimetidine on desipramine metabolism between rapid and slow debrisoquin hydroxylators.
    Steiner E; Spina E
    Clin Pharmacol Ther; 1987 Sep; 42(3):278-82. PubMed ID: 3621781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype.
    Spina E; Steiner E; Ericsson O; Sjöqvist F
    Clin Pharmacol Ther; 1987 Mar; 41(3):314-9. PubMed ID: 3816019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
    von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
    J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
    Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
    Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.
    Spina E; Gitto C; Avenoso A; Campo GM; Caputi AP; Perucca E
    Eur J Clin Pharmacol; 1997; 51(5):395-8. PubMed ID: 9049581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
    Eichelbaum M; Tomson T; Tybring G; Bertilsson L
    Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.
    Khan AY; Preskorn SH; Horst WD
    J Pak Med Assoc; 2007 May; 57(5):230-5. PubMed ID: 17571477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes.
    Isobe T; Hichiya H; Hanioka N; Yamamoto S; Shinoda S; Funae Y; Satoh T; Yamano S; Narimatsu S
    Biol Pharm Bull; 2005 Apr; 28(4):634-40. PubMed ID: 15802801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desipramine hydroxylation: variability and effect of antipsychotic drugs.
    Bock JL; Nelson JC; Gray S; Jatlow PI
    Clin Pharmacol Ther; 1983 Mar; 33(3):322-8. PubMed ID: 6130865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmethylimipramine overdose: nonlinear kinetics in a slow hydroxylator.
    Spina E; Henthorn TK; Eleborg L; Nordin C; Säwe J
    Ther Drug Monit; 1985; 7(2):239-41. PubMed ID: 4024220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults.
    Nichols AI; Abell M; Chen Y; Behrle JA; Frick G; Paul J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):99-105. PubMed ID: 23221858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.